FAMILY DOCTOR WANNABE
  • Home
  • About
  • Blog
  • Learn Medicine
  • Contact

I'll be back. Currently meditating...

UBC Objectives: Women's Health, UBC Objectives: Care of Men, Priority Topic: Cancer, Priority Topic: Periodic Health Assessment/Screening, & Priority Topic: Prostate

7/5/2018

0 Comments

 
By the end of postgraduate training, using a patient-centred approach and appropriate selectivity, a resident, considering the patient’s cultural and gender contexts, will be able to...
  • Apply Canadian guidelines for gynecologic cancer screening with PAP testing and options for vaccinations

Cancer

Key Feature 2: In all patients, provide the indicated evidence-based screening (according to age group, risk factors, etc.) to detect cancer at an early stage (ex: with Pap tests, mammography, colonoscopy, digital rectal examinations, prostate-specific antigen testing).
Skill: Clinical Reasoning, Selectivity
Phase: Diagnosis

Periodic Health Assessment/Screening

Key Feature 2: In any given patient, selectively adapt the periodic health examination to that patient’s specific circumstances (i.e., adhere to inclusion and exclusion criteria of each manoeuvre/intervention, such as the criteria for mammography and prostate-specific antigen [PSA] testing).
Skill: Selectivity, Patient Centered
Phase: Investigation, Hypothesis generation

Key Feature 3a: In a patient requesting a test (ex: PSA testing, mammography) that may or may not be recommended: Inform the patient about limitations of the screening test (i.e., sensitivity and specificity).
Skill: Clinical Reasoning
Phase: Treatment, Investigation

Key Feature 3b: In a patient requesting a test (ex: PSA testing, mammography) that may or may not be recommended: Counsel the patient about the implications of proceeding with the test.
Skill: Clinical Reasoning, Patient Centered
Phase: Treatment, Investigation

Key Feature 4: Keep up to date with new recommendations for the periodic health examination, and critically evaluate their usefulness and application to your practice.
Skill: Professionalism
Phase: Treatment, Diagnosis

Prostate

Key Feature 1: Appropriately identify patients requiring prostate cancer screening.
Skill: Selectivity
Phase: Diagnosis, History

Key Feature 6: Given a suspicion of benign prostatic hypertrophy, diagnose it using appropriate history, physical examination, and investigations.
Skill: Clinical Reasoning
Phase: Diagnosis

Today I will be doing a Pap clinic with the Portland Hotel Society. Although I've done many Pap smears during my training, this afternoon will be great to refine my skill at performing this procedure. The population I will be screening will be women from the Downtown East Side (DTES) of Vancouver, often with significant histories of trauma, higher rates of infection include sexually transmitted ones, and who may present infrequently for care. I am not exactly sure what to expect, but I am looking forward to learning from these women. 

The Pap test is a screening test to look for evidence of cervical cancer. It is not a test for sexually transmitted infections (STIs), although many people think it is (and I know that's what I used to think before entering Medicine). So it is important to consider that women who present for Pap tests may really be more concerned about a possible STI. I expect this may be the case with the sample of patients I screen today, given their risk factors. Nevertheless, this provides an opportunity to perform both cervical cancer screening and STI testing (or screening), if indicated. STI screening or testing can also be done without collecting a Pap smear, and indeed it is a waste of resources if Pap tests or any other forms of cancer screening tests are overdone. If women are concerned about STIs, it's also an opportunity to ask about immunization against HPV. Nowadays Canadian students are offered this vaccination during the middle school years, but it is a relatively new initiative and so many people are not covered. When STI screening comes up, or when patients present for a Pap, I use this as an opportunity to discuss HPV vaccination for those who may not be covered and who are at increased risk (the HPV vaccine is recommended in all women up until the age of 45, in all males age 9-26, and in men who have sex with men [MSM]). This vaccine helps to prevent transmission of strains of HPV that can precipitate cellular transformations that can then lead to cervical, oral, anal, and penile cancer.

The recommendations by the Canadian Task Force on Preventive Health Care give the following recommendations for cancer screening, given the sensitivity and specificity of available screening tests within a landscape influenced by logistics, economics, and politics. Note that for those patients who meet exclusion criteria for recommendations, consider referring to local (provincial) screening guideline for guidance. Some patients may present inquiring about or actually requesting screening investigations when it is not recommended according to guidelines. It is important to remember that guidelines are not the law of how to practice medicine, but rather offer guidance in a context of having to make so many medical decisions in a day, which is also in the language of the guideline "recommendations" themselves. For any patients for which screening investigations are recommended according to guidelines, it is always important to remember to obtain informed consent, which includes patient understanding as to why a test is being done and what the likely outcomes are. Just because a screening intervention may be recommended for a given population by guideline authorities, it does not mean that every individual within that population will want and choose to do the test. #patientcenteredcare

Cervical Cancer Screening Recommendations

Exclusion criteria
Recommendations are presented for screening asymptomatic women who are or have been sexually active. They do not apply to women with symptoms of cervical cancer, previous abnormal screening results (until they have been cleared to resume normal screening), those who do not have a cervix (due to hysterectomy), or who are immunosuppressed.

Recommendations
  1. For women aged < 25 we recommend not routinely screening for cervical cancer
  2. For women aged 25 to 69 we recommend routine screening for cervical cancer every 3 years.
  3. For women aged ≥ 70 who have been adequately screened (i.e., 3 successive negative Pap tests in the last 10 years), we recommend that routine screening may cease. For women aged 70 or over who have not been adequately screened we recommend continued screening until 3 negative test results have been obtained.

Breast Cancer Screening Recommendations

Exclusion criteria
Recommendations are presented for the use of mammography, magnetic resonance imaging, breast self exam and clinical breast exam to screen for breast cancer. These recommendations apply only to women at average risk of breast cancer aged 40 to 74 years. They do not apply to women at higher risk due to personal history of breast cancer, history of breast cancer in first degree relative, known BRCA1/BRCA2 mutation, or prior chest wall radiation. No recommendations are made for women aged 75 and older, given the lack of data.

Recommendations
  1. For women aged 50–74 years we recommend routinely screening with mammography every 2 to 3 years.
  2. We recommend not routinely screening with magnetic resonance imaging.
  3. We recommend not advising women to routinely practice Breast Self Exam.
  4. We recommend not routinely performing Clinical Breast Exam alone or in conjunction with mammography to screen for breast cancer.

Colorectal Cancer Screening Recommendations

Exclusion criteria
These recommendations apply to adults aged ≥50 years who are not at high risk for colorectal cancer (CRC). They do not apply to those with previous CRC or polyps, inflammatory bowel disease, signs or symptoms of CRC, history of CRC in one or more first degree relatives, or adults with hereditary syndromes predisposing to CRC (ex: familial adenomatous polyposis, Lynch Syndrome).

Recommendations
  1. We recommend screening adults aged 50 to 74 for CRC with FOBT (either gFOBT or FIT) every two years OR flexible sigmoidoscopy every 10 years.
  2. We recommend not screening adults aged 75 years and over for CRC.
  3. We recommend not using colonoscopy as a screening test for CRC.

Lung Cancer Screening Recommendations

Exclusion criteria
These recommendations apply to adults aged 18 years and older who are not suspected of having lung cancer. These recommendations do not apply to individuals who have a history of lung cancer, or suspected lung cancer.

Recommendations
  1. For adults aged 55-74 years with at least a 30 pack-year* smoking history who currently smoke or quit less than 15 years ago, we recommend annual screening with Low Dose Computed Tomography (LDCT) up to three consecutive times. Screening should ONLY be carried out in health care settings with expertise in early diagnosis and treatment of lung cancer.
    *Pack-year defined as the (average number of cigarette packs smoked daily) x (number of years smoking)
  2. For all other adults, regardless of age, smoking history or other risk factors, we recommend not screening for lung cancer with LDCT.
  3. We recommend that chest x-ray not be used to screen for lung cancer, with or without sputum cytology.

Prostate Cancer Screening Recommendations

Exclusion criteria
This clinical practice guideline applies to all men not previously diagnosed with prostate cancer. This includes men with lower urinary tract symptoms (nocturia, urgency, frequency and poor stream) or with benign prostatic hyperplasia (BPH).*

Recommendations
  1. For all men, we recommend not screening for prostate cancer with the prostate-specific antigen test.
  2. For all men, we recommend not screening for prostate cancer with Digital Rectal Examination (DRE).

*Note that BPH and prostate cancer may present with the same lower urinary tract symptoms, so when making a diagnosis of BPH it's important to ensure there are no symptoms or signs suggestive of malignancy (or other diagnoses such as prostatitis), and that the PSA is not abnormally elevated. In this setting, the measurement of a normal PSA is done to assist in the diagnostic workup of BPH rather than as a screening test for prostate cancer, which would be done only if a male did not have any symptoms suggesting a current diagnosis of prostate cancer. If a man is diagnosed with BPH that responds well to treatment, recurrent testing of PSA in the interest of screening for prostate cancer is not indicated.
0 Comments



Leave a Reply.

    RSS Feed

    Categories

    All
    Abdominal Pain
    Addiction Medicine
    Advanced Cardiac Life Support
    Allergy
    Anemia
    Antibiotics
    Anxiety
    Asthma
    Atrial Fibrillation
    Bad News
    Behavioural Medicine & Resident Wellness
    Behavioural Problems
    Breast Lump
    Cancer
    Care Of Children + Adolescents
    Care Of Men
    Care Of The Elderly
    Chest Pain
    Chronic Disease
    Chronic Obstructive Pulmonary Disease
    Collaborator
    Communicator
    Contraception
    Cough
    Counselling
    Crisis
    Croup
    Dehydration
    Dementia
    Depression
    Diabetes
    Diarrhea
    Difficult Patient
    Disability
    Dizziness
    Domestic Violence
    Dysuria
    Earache
    Eating Disorders
    Elderly
    Family Medicine
    Fatigue
    Fever
    Fractures
    Gender Specific Issues
    Genitourinary & Women's Health
    Grief
    Health Advocate
    HIV Primary Care
    Hypertension
    Immigrants
    Immunization
    In Children
    Infections
    Infertility
    Injections & Cannulations
    Insomnia
    Integumentary
    Ischemic Heart Disease
    Lacerations
    Learning (Patients)
    Learning (Self Learning)
    Manager
    Maternity Care
    Meningitis
    Menopause
    Mental Competency
    Mental Health
    Multiple Medical Problems
    Newborn
    Obesity
    Obstetrics
    Osteoporosis
    Palliative Care
    Periodic Health Assessment/Screening
    Personality Disorder
    Pneumonia
    Poisoning
    Pregnancy
    Priority Topic
    Procedures
    Professional
    Prostate
    Rape/Sexual Assault
    Red Eye
    Resuscitation
    Schizophrenia
    Sex
    Sexually Transmitted Infections
    Smoking Cessation
    Somatization
    Stress
    Substance Abuse
    Suicide
    Surgical + Procedural Skills
    Transition To Practice
    Trauma
    Urinary Tract Infection
    Vaginal Bleeding
    Vaginitis
    Violent/Aggressive Patient
    Well Baby Care
    Well-baby Care
    Women's Health

Proudly powered by Weebly
  • Home
  • About
  • Blog
  • Learn Medicine
  • Contact